|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Nov 23, 2006 |
Title |
Gene expression in Stage 1,2 Normal and Tumor kidney cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Although renal cell carcinoma (RCC) is the sixth-leading cause of cancer death, the molecular events leading to disease onset and progression are not well understood. Genomic profiling of clear cell RCC (cRCC) patients indicated that loss of a negative regulator of the Wnt pathway, secreted frizzled-related protein 1 (sFRP1), occurred in the majority of more than 100 patients tested. To our knowledge, this is the first report of loss of sFRP1 expression in patients diagnosed with cRCC; this loss occurs in early stage cRCC, suggesting that it may be an important early event in renal carcinogenesis. Genomic profiling of patient matched normal and cRCC tissues identified Wnt regulated genes to be aberrantly increased in cRCC tissues suggesting sFRP1 suppresses Wnt signaling in cRCC. In order to test the hypothesis that sFRP1 acts as a tumor suppressor in cRCC, we have stably expressed sFRP1 in cRCC cells. sFRP1 expression in cRCC cells resulted in decreased growth in cell culture, inhibition of anchorage-independent growth, and decreased tumor volume in a nude mouse model. Together these data suggest an important role for sFRP1 as a tumor suppressor in cRCC. Keywords: Disease state analysis
|
|
|
Overall design |
5pts on Stg1 Normal and Tumor and 5pts on Stg2 normal and tumor each
Additional information may be found in the following supplementary files:
1) GSE6344_Combofiles.zip - contains all text files for combination tables. 2) GSE6344_Dataframe.TXT - contains the Dataframe after filters and normalizations for differential testing. 3) GSE6344_MethodsDetails.PDF - describes the steps for creating the combination tables from HG-U133 A, B set and also the method for normalizations and filters. 4) GSE6344_a1way_StageTumor_@95(@99).txt - contain results from Anova 1 way at p-values<=0.05 and 0.01.
|
|
|
Contributor(s) |
Copland JA |
Citation(s) |
17699851, 20502531 |
|
Submission date |
Nov 21, 2006 |
Last update date |
Aug 10, 2018 |
Contact name |
John A Copland |
E-mail(s) |
Copland.John@mayo.edu
|
Organization name |
Mayo Clinic College of Medicine
|
Department |
Biochemistry & Molecular Biology
|
Street address |
4500 San Pablo Road
|
City |
Jacksonville |
State/province |
FL |
ZIP/Postal code |
32224 |
Country |
USA |
|
|
Platforms (2) |
GPL96 |
[HG-U133A] Affymetrix Human Genome U133A Array |
GPL97 |
[HG-U133B] Affymetrix Human Genome U133B Array |
|
Samples (40)
|
GSM146781 |
Stage 1, PT#3, Tumor (HG-U133A) |
GSM146782 |
Stage 1, PT#4, Normal (HG-U133A) |
GSM146783 |
Stage 1, PT#4,Tumor (HG-U133A) |
GSM146784 |
Stage 1, PT#5,Normal (HG-U133A) |
GSM146785 |
Stage 1, PT#5, Tumor (HG-U133A) |
GSM146786 |
Stage 1, PT#6, Normal (HG-U133A) |
GSM146787 |
Stage 1, PT#6,Tumor (HG-U133A) |
GSM146788 |
Stage 2, PT#8, Tumor (HG-U133A) |
GSM146789 |
Stage 2, PT#8, Normal (HG-U133A) |
GSM146790 |
Stage 2, PT#9, Normal (HG-U133A) |
GSM146791 |
Stage 2, PT#9, Tumor (HG-U133A) |
GSM146792 |
Stage 2, PT#10, Normal (HG-U133A) |
GSM146793 |
Stage 2, PT#10, Tumor (HG-U133A) |
GSM146794 |
Stage 2, PT#11, Normal (HG-U133A) |
GSM146795 |
Stage 2, PT#11, Tumor (HG-U133A) |
GSM146796 |
Stage 2, PT#12, Normal (HG-U133A) |
GSM146797 |
Stage 2, PT#12, Tumor (HG-U133A) |
GSM146798 |
Stage 1, PT#2, Normal (HG-U133B) |
GSM146799 |
Stage 1, PT#2, Tumor (HG-U133B) |
GSM146800 |
Stage 1, PT#3, Normal (HG-U133B) |
GSM146801 |
Stage 1, PT#3, Tumor (HG-U133B) |
GSM146802 |
Stage 1, PT#4, Normal (HG-U133B) |
GSM146803 |
Stage 1, PT#4,Tumor (HG-U133B) |
GSM146804 |
Stage 1, PT#5,Normal (HG-U133B) |
GSM146805 |
Stage 1, PT#5, Tumor (HG-U133B) |
GSM146806 |
Stage 1, PT#6, Normal (HG-U133B) |
GSM146807 |
Stage 1, PT#6,Tumor (HG-U133B) |
GSM146808 |
Stage 2, PT#8, Tumor (HG-U133B) |
GSM146809 |
Stage 2, PT#8, Normal (HG-U133B) |
GSM146810 |
Stage 2, PT#9, Normal (HG-U133B) |
GSM146811 |
Stage 2, PT#9, Tumor (HG-U133B) |
GSM146812 |
Stage 2, PT#10, Normal (HG-U133B) |
GSM146813 |
Stage 2, PT#10, Tumor (HG-U133B) |
GSM146814 |
Stage 2, PT#11, Normal (HG-U133B) |
GSM146815 |
Stage 2, PT#11, Tumor (HG-U133B) |
GSM146816 |
Stage 2, PT#12, Normal (HG-U133B) |
GSM146817 |
Stage 2, PT#12, Tumor (HG-U133B) |
|
Relations |
BioProject |
PRJNA99609 |
Supplementary file |
Size |
Download |
File type/resource |
GSE6344_Combofiles.zip |
4.8 Mb |
(ftp)(http) |
ZIP |
GSE6344_Dataframe.TXT |
3.8 Mb |
(ftp)(http) |
TXT |
GSE6344_MethodsDetails.PDF |
12.4 Kb |
(ftp)(http) |
PDF |
GSE6344_RAW.tar |
130.6 Mb |
(http)(custom) |
TAR (of CEL) |
GSE6344_a1way_StageTumor_@95.txt |
2.4 Mb |
(ftp)(http) |
TXT |
GSE6344_a1way_StageTumor_@99.txt |
1.6 Mb |
(ftp)(http) |
TXT |
|
|
|
|
|